Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) ("Kane Biotech", "Kane" or the "Company") today announces its third quarter 2024 financial results. Third ...
Product sales for the three months ended September 30, 2024 was $597,677 compared to $3,631 in the three months ended ...
The healthcare technology market is well-poised for long-term growth, thanks to the growing demand for medical devices, ...
The deal will see the Mexican medical network distribute Lunit’s INSIGHT CXR and INSIGHT MMG software to over 230 clinical ...
While we think Terumo can deliver its top-line growth, an operating margin of 20% is unlikely. First, for the C&V division, Terumo is in the ramp-up phase for its newly launched neurovascular or ...
BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyve TM Antimicrobial Wound Gel reflects BioStem’s continued commitment to building a diverse ...
Q4 2024 Earnings Call Transcript November 26, 2024 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...
Orthocell (ASX:OCC) has appointed Device Technologies Asia as the exclusive distributor of its nerve repair device, Remplir, ...
Orthocell appoints Device Technologies Asia as exclusive distributor of nerve-repair product Remplir in Singapore. ... Read ...
Although initially started as a microscope and camera maker 100 years ago, Olympus is now a dedicated medical device company focusing on endoscopic and surgical solutions. We expect Olympus to enjoy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback